Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Senior Management
Scientific Advisory Board
Corporate Governance
Programs
Xolatryp
Myocardial Ischemia and Arrhythmia Control
Stroke
Traumatic Brain Injury
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
ASX Announcements
Filter by Year:
2026
2025
2024
2023
2022
2021
2020
8-Oct-2025
Initial Director's Interest Notice - JB
8-Oct-2025
Nyrada Board Transition and CEO Remuneration Review
2-Oct-2025
Cleansing Statement
2-Oct-2025
Application for quotation of securities - NYR
1-Oct-2025
Nyrada 2025 Equity Incentive Plan
29-Sep-2025
Xolatryp Achieves Key Clinical Milestone
16-Sep-2025
Xolatryp Protects Cells through Mitochondrial Stabilisation
11-Sep-2025
Change in substantial holding - M Azzi
9-Sep-2025
Cleansing Statement
9-Sep-2025
Application for quotation of securities - NYR
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
Next
